Glial Purinergic Signaling in Neurodegeneration - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue Frontiers in Neurology Année : 2021

Glial Purinergic Signaling in Neurodegeneration

Résumé

Purinergic signaling regulates neuronal and glial cell functions in the healthy CNS. In neurodegenerative diseases, purinergic signaling becomes dysregulated and can affect disease-associated phenotypes of glial cells. In this review, we discuss how cell-specific expression patterns of purinergic signaling components change in neurodegeneration and how dysregulated glial purinergic signaling and crosstalk may contribute to disease pathophysiology, thus bearing promising potential for the development of new therapeutical options for neurodegenerative diseases.

Domaines

Neurobiologie
Fichier principal
Vignette du fichier
fneur-12-654850.pdf (1.71 Mo) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

inserm-03385134 , version 1 (19-10-2021)

Identifiants

Citer

Marie Pietrowski, Amr Ahmed Gabr, Stanislav Kozlov, David Blum, Annett Halle, et al.. Glial Purinergic Signaling in Neurodegeneration. Frontiers in Neurology, 2021, 12, pp.654850. ⟨10.3389/fneur.2021.654850⟩. ⟨inserm-03385134⟩
26 Consultations
108 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More